Skip to main content
Clinical Trials/NCT03031964
NCT03031964
Terminated
Not Applicable

Survivorship, Clinical and Functional Outcomes of the Multihole Revision Acetabular Cup

The Cleveland Clinic1 site in 1 country24 target enrollmentDecember 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Complications Arthroplasty
Sponsor
The Cleveland Clinic
Enrollment
24
Locations
1
Primary Endpoint
survivorship of a multihole revision acetabular cup
Status
Terminated
Last Updated
4 years ago

Overview

Brief Summary

This study will evaluate patients receiving a multihole revision acetabular implant for total hip arthroplasty (THA) and will be followed for 10 years to collect data on survivorship of the implanted prosthesis.

Detailed Description

Data will be collected preoperatively, and at the standard of care (SOC) office visits at 4 weeks, 1 year, 2 years, 5 years and 10 years postoperatively. The research coordinator at each site will identify, recruit, and prospectively follow the 60 patients at his/her site. Patient demographics (e.g., age, gender, body mass index (BMI)), comorbidities, reason for revision, Paprosky classification, native femoral head measurement (mm) etc. will be collected preoperatively. The study coordinator will contact patients prior to each visit to ensure patient compliance. At each visit, A-P and cross-lateral radiographic evaluation (i.e., use of Engh classification to quantify osteolysis/loosening) will occur. In addition, patients will be assessed for any complications (e.g., dislocation, emergency department visits, infection, reoperation, etc.). Patients will complete the Hip disability and Osteoarthritis Outcome Score (HOOS) and Veterans Rand 12 (VR-12) forms (including a specific question regarding groin pain) and a pain assessment. In the event that a patient has relocated and/or refuses to return to the office for the 5-year visit, a script will be sent to the patient to have x-rays done and sent to the PI, and questionnaires will be mailed. All data will be entered and maintained in RedCap.

Registry
clinicaltrials.gov
Start Date
December 2016
End Date
January 2022
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Carlos Higuera-Rueda

Staff Surgeon

The Cleveland Clinic

Eligibility Criteria

Inclusion Criteria

  • Patients requiring revision total hip replacement of the acetabular component or complicated primary total hip replacement.
  • Femoral stem (either retained or replaced) is a compatible Stryker stem.
  • Patient is willing to comply with follow-up requirements (e.g. will return for long-term follow-up visits)
  • Age: 18-85 years

Exclusion Criteria

  • Patient has a BMI \> 40
  • Exclude revision for infection
  • Patient is undergoing bilateral THA surgery or had prior hip arthroplasty on contralateral side less than 6 months from date of surgery
  • Patient has history of radiation therapy
  • Patient has known diagnosis of renal disease
  • Patient has known diagnosis of osteoporosis

Outcomes

Primary Outcomes

survivorship of a multihole revision acetabular cup

Time Frame: 10 years

evaluate standard of care radiographs for any signs of implant compromise such as loosening or osteolysis

Secondary Outcomes

  • functional outcomes of multihole revision acetabular cup(10 years)
  • assess pain levels in patients who receive multihole revision acetabular cup(10 years)
  • Clinical outcomes of multihole revision acetabular cup(10 years)

Study Sites (1)

Loading locations...

Similar Trials